Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01.06.22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02.01.15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01.07.11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01.06.22 |
Gen Li
BRD | Director/Board Member | - | 27.04.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Unternehmenskontakt
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+19.98% | 43.48 Mrd. | |
+20.67% | 22.65 Mrd. | |
+14.56% | 14.73 Mrd. | |
+14.32% | 13.79 Mrd. | |
+44.72% | 12.04 Mrd. | |
-8.37% | 7.08 Mrd. | |
-0.05% | 6.79 Mrd. | |
-8.87% | 5.73 Mrd. | |
+11.90% | 5.47 Mrd. |